London Daily

Focus on the big picture.
Friday, Jun 20, 2025

Tests show China’s Sinovac vaccine is safe, Brazil research centre says

Tests show China’s Sinovac vaccine is safe, Brazil research centre says

Company is first drug maker to disclose late stage trial results, putting China ahead in race to develop Covid-19 shot.
An experimental vaccine developed by China’s Sinovac Biotech appeared to be safe in providing protection against the Covid-19 disease caused by the new coronavirus, preliminary results of a late stage clinical trial conducted in Brazil showed on Monday.

Sinovac is the first drug maker to disclose late stage trial results, putting China ahead in attempts to develop a coronavirus vaccine to fight against a pandemic that has killed over 1 million people globally.

Sao Paulo’s Butantan Institute, one of Brazil’s leading biomedical research centres that is carrying out the phase 3 tests, said the vaccine called Coronavac proved to be safe after its two doses were applied to 9,000 volunteers.

But Butantan director Dimas Covas said data on how effective the vaccine is in protecting people against the new coronavirus will not be released until it has been tested on all of the 15,000 volunteers in expanded trials.

Sao Paulo state health secretary Jean Gorinchteyn said the vaccines appeared to produce protective antibodies. The state is hoping to obtain regulatory approval for Coronavac by the end of the year to start inoculating its population early in 2021.

Sinovac needed Brazil as a testing ground since it has been one of the global hotbeds of the virus, although cases are 43 per cent off their peak of nearly 70,000.

Brazil has reported more than 5.2 million Covid-19 cases since the pandemic began, the world’s third most affected country after the United States and India.

AstraZeneca and Oxford University are nearing an analysis of their British trial. Pfizer has said it could provide an early analysis of its trial this month and Moderna may announce its results in November.

Russia’s Gamaleya Institute may also provide an analysis of its vaccine in the next month.

Pfizer and Moderna were both nearly fully enrolled at last count, with Pfizer’s at 38,000 out of 40,000 people as of one week ago and Moderna several hundred people short of the 30,000 people it plans to sign up as of Friday.

Competing candidates developed by AstraZeneca and Johnson & Johnson have had their trials halted in the United States due to safety issues.
Newsletter

Related Articles

0:00
0:00
Close
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
Plans to Sell Dutch Embassy in Bangkok Face Local Opposition
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump's $5 Million 'Trump Card' Visa Program Draws Nearly 70,000 Applicants
DGCA Finds No Major Safety Concerns in Air India's Boeing 787 Fleet
Airlines Reroute Flights Amid Expanding Middle East Conflict Zones
Elon Musk's xAI Seeks $9.3 Billion in Funding Amid AI Expansion
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Taiwan Imposes Export Ban on Chips to Huawei and SMIC
Israel has just announced plans to strike Tehran again, and in response, Trump has urged people to evacuate
Netanyahu Signals Potential Regime Change in Iran
Juncker Criticizes EU Inaction on Trump Tariffs
EU Proposes Ban on New Russian Gas Contracts
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
UK Home Secretary Apologizes Over Child Grooming Failures
Trump Organization Launches 5G Mobile Network and Golden Handset
Towcester Hosts 2025 English Greyhound Derby Amid Industry Scrutiny
Gary Oldman and David Beckham Knighted in King's Birthday Honours
Over 30,000 Lightning Strikes Recorded Across UK During Overnight Storms
Princess of Wales Returns to Public Duties at Trooping the Colour
Red Arrows Use Sustainable Fuel in Historic Trooping the Colour Flypast
Former Welsh First Minister Addresses Unionist Concerns Over Irish Language
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
France Bars Israeli Arms Companies from Paris Defense Expo
King Charles Leads Tribute to Air India Crash Victims at Trooping the Colour
Jack Pitchford Embarks on 200-Mile Walk to Support Stem Cell Charity
Surrey Hikers Take on Challenge of Climbing 11 Peaks in a Single Day
UK Deploys RAF Jets to Middle East Amid Israel-Iran Tensions
Two Skydivers Die in 'Tragic Accident' at Devon Airfield
Sainsbury's and Morrisons Accused of Displaying Prohibited Tobacco Ads
UK Launches National Inquiry into Grooming Gangs
Families Seek Closure After Air India Crash
Gold Emerges as Global Safe Haven Amid Uncertainty
Trump Reports $57 Million Earnings from Crypto Venture
Trump's Military Parade Sparks Concerns Over Authoritarianism
Nationwide 'No Kings' Protests Challenge Trump's Leadership
UK Deploys Jets to Middle East Amid Rising Tensions
Trump's Anti-War Stance Tested Amid Israel-Iran Conflict
Germany Holds First Veterans Celebration Since WWII
U.S. Health Secretary Dismisses CDC Vaccine Advisory Committee
Minnesota Lawmaker Melissa Hortman and Husband Killed in Targeted Attack; Senator John Hoffman and Wife Injured
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
×